Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027
Pfizer Inc. (NYSE:PFE) has launched a multi-year cost-cutting initiative aimed at saving approximately $1.5 billion by the end of 2027.What Happened: The new program builds on a $4 billion cost reduct
Pfizer, Moderna in Talks With HHS Over Avian Flu Vaccine: Report
Moderna, BioNTech Close With Double-digit Percentage Gains Amid Bird Flu Fears
Bristol-Myers Squibb Snaps Six Days of Losses, Trades in the Green
Bristol-Myers Squibb (NYSE:BMY) shares traded in the green on Tuesday, breaking six straight days of losses.
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb
Shares of vaccine producers' stocks are trading higher Wednesday on reports indicating disease experts predict a small rise in COVID-19 cases this summer.The Details:According to a report from NBC New
COVID-19 Vaccine Makers Rebound Amid Post-pandemic Prospects